Evidence map›Paper›PMID 29118105›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis.

Thomas Grund, Stephanie Goyon, Yuting Li, Marina Eliava, Haikun Liu, Alexandre Charlet, Valery Grinevich, Inga D Neumann

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Monitoring oxytocin signaling in the brain: More than a love story.Comprehensive psychoneuroendocrinology · 2023
    Review
  10. Article
  11. Review
  12. A Role for Neuropeptide S in Alcohol and Cocaine Seeking.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thomas GrundDepartment of Behavioral and Molecular Neurobiology, Regensburg Center of Neuroscience, University of Regensburg, 93040 Regensburg, Germany.
Stephanie GoyonInstitute of Cellular and Integrative Neurosciences UPR3212, Centre National de la Recherche Scientifique, University of Strasbourg, 67084 Strasbourg, France.
Yuting LiDivision of Molecular Neurogenetics, German Cancer Research Center, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, Heidelberg 69120, Germany.
Marina EliavaDivision of Neuropeptides (V078), German Cancer Research Center, Central Institute of Mental Health, CellNetwork Cluster of Excellence, University of Heidelberg, 69120 Heidelberg, Germany, and.
Haikun LiuDivision of Molecular Neurogenetics, German Cancer Research Center, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, Heidelberg 69120, Germany.
Alexandre CharletInstitute of Cellular and Integrative Neurosciences UPR3212, Centre National de la Recherche Scientifique, University of Strasbourg, 67084 Strasbourg, France.ORCID 0000-0003-4837-3706
Valery GrinevichDivision of Neuropeptides (V078), German Cancer Research Center, Central Institute of Mental Health, CellNetwork Cluster of Excellence, University of Heidelberg, 69120 Heidelberg, Germany, and.
Inga D NeumannDepartment of Behavioral and Molecular Neurobiology, Regensburg Center of Neuroscience, University of Regensburg, 93040 Regensburg, Germany, inga.neumann@ur.de.
German Cancer Research Center · DEInstitut des Neurosciences Cellulaires et Intégratives · FRUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropeptides, such as neuropeptide S (NPS) and oxytocin (OXT), represent potential options for the treatment of anxiety disorders due to their potent anxiolytic profile. In this study, we aimed to reveal the mechanisms underlying the behavioral action of NPS, and present a chain of evidence that the effects of NPS within the hypothalamic paraventricular nucleus (PVN) are mediated via actions on local OXT neurons in male Wistar rats. First, retrograde studies identified NPS fibers originating in the brainstem locus coeruleus, and projecting to the PVN. FACS identified prominent NPS receptor expression in PVN-OXT neurons. Using genetically encoded calcium indicators, we further demonstrated that NPS reliably induces a transient increase in intracellular Ca

Indexed as

AnimalsAnxietyAxonal TransportBacterial ProteinsCalcium SignalingDependovirusExploratory BehaviorGenes, ReporterGenetic VectorsLuminescent ProteinsMaleMicrodialysisMotor ActivityNeuropeptidesOxytocinParaventricular Hypothalamic NucleusBacterial ProteinsLuminescent ProteinsNeuropeptidesneuropeptide S, ratneuropeptide S receptor, ratOxytocinoxytocin receptor, ratReceptors, NeuropeptideReceptors, OxytocinRed Fluorescent Proteinyellow fluorescent protein, BacteriaanxietyDREADDGCaMP6smicrodialysisneuropeptide Soxytocin

Identifiers

PMID29118105
PMCPMC6596824
OpenAlexW2767736216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.